MAP2K1 and Miyoshi myopathy: Production of IL-6 by stromal cells is of relevance in MM, as evidenced by the induction of PD-L1 by IL-6 on human myeloma cell lines, which can be downregulated by inhibiting STAT3, MEK1/2, or JAK2 [11].